Teresa Brophy Bair, Chief Legal Officer at Kura Oncology, Inc. (KURA), sold 5,230 shares at $22.15 ($116K) on 2024-05-20, disclosed to the SEC on 2024-05-20.
Scheduled sale ($116k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.15 | 2,615 | $58K | 50.0% |
| 2 | $22.15 | 2,615 | $58K | 50.0% |
| Total | $22.15 avg | 5,230 | $116K | 100% |
| Filing → |
| KURA | SELL | 2026-05-20 | $21K | — | Filing → |
| KURA | SELL | 2026-01-27 | $95K | — | Filing → |
| KURA | SELL | 2025-11-14 | $197K | — | Filing → |